These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8912483

  • 1. Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J.
    Arch Neurol; 1996 Nov; 53(11):1103-9. PubMed ID: 8912483
    [Abstract] [Full Text] [Related]

  • 2. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, Konishi J, Kimura J.
    Arch Neurol; 1998 May; 55(5):609-14. PubMed ID: 9605717
    [Abstract] [Full Text] [Related]

  • 3. Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.
    Yamauchi H, Fukuyama H, Dong Y, Nabatame H, Nagahama Y, Nishizawa S, Konishi J, Shio H.
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):317-22. PubMed ID: 10675213
    [Abstract] [Full Text] [Related]

  • 4. Callosal atrophy with reduced cortical oxygen metabolism in carotid artery disease.
    Yamauchi H, Fukuyama H, Nabatame H, Harada K, Kimura J.
    Stroke; 1993 Jan; 24(1):88-93. PubMed ID: 8418557
    [Abstract] [Full Text] [Related]

  • 5. Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxygen metabolism after carotid artery occlusion: a follow up study with MRI and PET.
    Yamauchi H, Pagani M, Fukuyama H, Ouchi Y, Nagahama Y, Matsuzaki S, Kimura J, Yonekura Y, Konishi J.
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):420-6. PubMed ID: 7561923
    [Abstract] [Full Text] [Related]

  • 6. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J.
    Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
    [Abstract] [Full Text] [Related]

  • 7. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease.
    Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, Kimura J, Konishi J.
    Arch Neurol; 1993 Oct; 50(10):1070-4. PubMed ID: 8215966
    [Abstract] [Full Text] [Related]

  • 8. Callosal atrophy in patients with lacunar infarction and extensive leukoaraiosis. An indicator of cognitive impairment.
    Yamauchi H, Fukuyama H, Ogawa M, Ouchi Y, Kimura J.
    Stroke; 1994 Sep; 25(9):1788-93. PubMed ID: 8073459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis.
    Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI.
    Arch Neurol; 1998 Feb; 55(2):193-8. PubMed ID: 9482361
    [Abstract] [Full Text] [Related]

  • 11. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ.
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [Abstract] [Full Text] [Related]

  • 12. Corpus callosum atrophy in amyotrophic lateral sclerosis.
    Yamauchi H, Fukuyama H, Ouchi Y, Nagahama Y, Kimura J, Asato R, Konishi J.
    J Neurol Sci; 1995 Dec; 134(1-2):189-96. PubMed ID: 8747865
    [Abstract] [Full Text] [Related]

  • 13. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
    Granberg T, Martola J, Bergendal G, Shams S, Damangir S, Aspelin P, Fredrikson S, Kristoffersen-Wiberg M.
    Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
    [Abstract] [Full Text] [Related]

  • 14. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study.
    Yamauchi H, Kudoh T, Kishibe Y, Iwasaki J, Kagawa S.
    J Nucl Med; 2005 Dec; 46(12):1973-9. PubMed ID: 16330559
    [Abstract] [Full Text] [Related]

  • 15. Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment.
    Yamauchi H, Fukuyama H, Shio H.
    Stroke; 2000 Jul; 31(7):1515-20. PubMed ID: 10884446
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, Konishi J, Shio H.
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
    Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI.
    Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337
    [Abstract] [Full Text] [Related]

  • 19. Diffuse tract damage in the hemispheric deep white matter may correlate with global cognitive impairment and callosal atrophy in patients with extensive leukoaraiosis.
    Otsuka Y, Yamauchi H, Sawamoto N, Iseki K, Tomimoto H, Fukuyama H.
    AJNR Am J Neuroradiol; 2012 Apr; 33(4):726-32. PubMed ID: 22210709
    [Abstract] [Full Text] [Related]

  • 20. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT.
    Neurology; 2017 Mar 28; 88(13):1265-1272. PubMed ID: 28235816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.